Skip to main content
. Author manuscript; available in PMC: 2017 Sep 2.
Published in final edited form as: Surgery. 2011 Dec;150(6):1023–1031. doi: 10.1016/j.surg.2011.09.021

Table 2.

Genome wide expression analysis in papillary thyroid cancer samples

Group Stratification Number of Differentially Expressed Genes FDR adjusted p-value Range (BH* method)
Mortality Presence vs. Absence 40 <0.05
Gender Male vs. Female 43 <0.05
Tumor differentiation Poorly vs. Well differentiated 115 <0.05
Age ≥ 45 vs. <45 Years 0 NS**
AMES risk classification Low-risk vs. high-risk 0 NS
Tumor size ≥ 4 vs. <4 cm. 0 NS
Lymph node metastasis Presence vs. Absence 0 NS
Extrathyroidal extension Presence vs. Absence 0 NS
Recurrent tumor Presence vs. Absence 0 NS
*

BH: Benjamini-Hochberg method

**

NS: not statistically significant